COA literacy
How to Read a Peptide Certificate of Analysis
A field guide to identity, purity, lot matching, dates, methods, and the limits of the document in front of you.
Research library
Evidence-focused guides to analytical methods, quality attributes, regulatory status, and supplier documentation.
Research pathways
These curated links help readers and crawlers move from the main research library into specific documentation, analytical-method, and compound evidence pages.
Educational collection
Every guide names its scope, limitations, updated date, and primary sources.
COA literacy
A field guide to identity, purity, lot matching, dates, methods, and the limits of the document in front of you.
Data literacy
Why a headline percentage is meaningful only when you know the method, calculation, sample, and missing measurements.
Laboratory standards
A practical way to assess laboratory identity, independence, accreditation scope, and report traceability.
Supplier standards
Documentation and business-practice signals that should trigger more questions before laboratory procurement.
Analytical methods
Two complementary techniques, two different questions, and why a complete report often needs both.
Peptide fundamentals
A plain-language introduction to amino-acid chains, sequence, structure, function, and why the word peptide describes a broad class—not a single effect.
Label literacy
Why research grade is not a universal regulatory quality standard—and which specifications and records matter more than the label.
Regulatory literacy
How to distinguish an approved drug product, an investigational drug, a compounded preparation, and a material sold for laboratory research.
Quality fundamentals
Five separate quality questions, the evidence used to address them, and why no single headline result can answer all five.
Peptide evidence
A plain-language evidence map separating laboratory findings, animal studies, limited human data, and the questions that remain unanswered.
Naming clarity
Why the names are often used interchangeably online, what the scientific literature actually studies, and what researchers should verify.
Naming clarity
A careful guide to CJC-1295 terminology, albumin binding, Mod GRF 1-29, and the labeling details researchers should confirm.
Peptide evidence
A grounded review of copper-binding GHK research across cell models, tissue-repair experiments, skin studies, and unresolved questions.
Peptide evidence
A research-use overview of MOTS-c evidence across cell models, animal metabolic studies, human biomarker research, clinical-trial status, and supplier documentation limits.
Peptide evidence
A clear evidence map for ipamorelin, separating receptor and animal findings, early human pharmacology, a phase 2 trial, and unanswered questions.
Naming clarity
A research-focused comparison of KP-10 and KP-54, including shared receptor biology, different in-vivo behavior, human evidence, and identity checks.
Peptide evidence
A stage-by-stage review of retatrutide receptor, animal, and human evidence—and why clinical-trial material is not equivalent to online research products.
Peptide evidence
A clear evidence map for tesamorelin, separating receptor and animal findings, the approved HIV-lipodystrophy evidence, broader human studies, and online product claims.
Research procurement
A research-use checklist for evaluating KPV listings, separating cell and animal findings from human evidence gaps and translating the chemistry into useful COA questions.
Peptide evidence
A stage-by-stage review of AOD-9604, separating cell and animal findings from the human obesity program, FDA's compounding review, and supplier-documentation questions.
Peptide evidence
A stage-by-stage review of thymosin alpha-1 (thymalfasin), separating cell and animal immune research, mixed human trial evidence, U.S. regulatory status, and supplier documentation.
Peptide evidence
A stage-by-stage review of LL-37 research, separating cell and animal findings, human wound trials, inflammatory signals, and supplier documentation.
Peptide evidence
A stage-by-stage review of bremelanotide and PT-141 receptor studies, animal models, phase 3 trials, FDA labeling, and research-vial documentation.
Peptide evidence
A stage-by-stage review of semaglutide design, receptor and animal studies, major human trials, FDA-approved products, and research-vial identity limits.
Peptide evidence
A stage-by-stage review of hexarelin, separating receptor and cell findings, animal cardiovascular models, small human studies, and research-material documentation.
Peptide evidence
A stage-by-stage review of sermorelin, separating receptor and animal findings, older human studies, historical FDA product status, and research-material documentation.
Peptide evidence
A stage-by-stage review of gonadorelin, separating receptor and cell findings, animal pulse-pattern research, human endocrine studies, FDA history, and research-material documentation.
Peptide evidence
A stage-by-stage review of Semax research, separating cell and animal findings, small human studies, regulatory status, and supplier-documentation limits.
COA literacy
A practical verification workflow for report numbers, laboratories, lot matching, document integrity, and unresolved evidence.
Analytical methods
A beginner-friendly guide to axes, peaks, retention time, integration, area percentage, resolution, and common interpretation limits.
Analytical methods
How expected mass, observed ions, charge states, adducts, resolution, and sample traceability contribute to identity evidence.
Material composition
Why acetate, trifluoroacetate, chloride, and other counterions affect composition, reporting, and cross-supplier comparisons.
Manufacturing literacy
How freeze-drying works, what a lyophilized cake can reveal, and why appearance does not establish content or stability.
Impurity testing
What residual solvents are, why peptide purity does not measure them, and how specifications and method-specific results should be reviewed.
Quantitative analysis
Why vial mass, residual moisture, counterions, purity, and quantitative peptide content are separate numbers.
Stability evidence
A framework for reviewing storage conditions, time points, stability-indicating methods, container systems, and extrapolated shelf-life claims.
Laboratory standards
How to check the accreditation body, certificate status, laboratory location, scope document, methods, and exclusions behind an ISO 17025 claim.
Sampling evidence
Why laboratory independence and sample independence are different—and how procurement, custody, and selection affect the strength of evidence.
Traceability
How lot definitions, sample identifiers, manufacturing records, and public COAs connect a test result to inventory.
Pricing literacy
A transparent comparison method for nominal quantity, verified content, testing, shipping, discounts, and documentation quality.
Stability analysis
How oxidation, deamidation, hydrolysis, and truncation change peptide materials—and what HPLC, LC-MS, stress studies, and supplier documents can actually establish.